Cargando…

Expression TGM2 and BNIP3 have prognostic significance in laryngeal cancer patients receiving surgery and postoperative radiotherapy: A retrospective study

BACKGROUND: This study was designed to determine the pattern and correlation between expression of the HIF-1α transcriptional targets TGM2 and BNIP3 in laryngeal cancer, and investigate the association of BNIP3 and TGM2 with clinical outcome in laryngeal squamous cell carcinoma (SCC) patients receiv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jin, Ting, Lin, Huan-Xin, Lin, Hui, Guo, Li-Bing, Ge, Nan, Cai, Xiu-Yu, Sun, Rui, Chen, Wen-Kuan, Li, Qiu-Li, Hu, Wei-Han
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3362769/ https://www.ncbi.nlm.nih.gov/pubmed/22458929 http://dx.doi.org/10.1186/1479-5876-10-64

Ejemplares similares

Treatment results and prognostic factors of patients undergoing postoperative radiotherapy for laryngeal squamous cell carcinoma
por: Jin, Ting, et al.
Publicado: (2011)

TGM2 knockdown reverses cisplatin chemoresistance in osteosarcoma
por: Li, Cuiyun, et al.
Publicado: (2018)

TGM2 inhibits the proliferation, migration and tumorigenesis of MDCK cells
por: Qiu, Zhenyu, et al.
Publicado: (2023)

Collodion Baby with TGM1 gene mutation
por: Sharma, Deepak, et al.
Publicado: (2015)

TGM4: an immunogenic prostate-restricted antigen
por: Lopez-Bujanda, Zoila A, et al.
Publicado: (2021)

Development and validation of the Trust in Government measure (TGM)
por: Burns, Kathleen E., et al.
Publicado: (2023)

TGM2-mediated histone transglutamination is dictated by steric accessibility
por: Lukasak, Bradley J., et al.
Publicado: (2022)

Postoperative Radiotherapy Omitting Level Ⅳ for Locally Advanced Supraglottic and Glottic Laryngeal Carcinoma
por: Wu, Yang, et al.
Publicado: (2021)

Tgm1-like transglutaminases in tilapia (Oreochromis mossambicus)
por: Rodriguez Cruz, Sandra I., et al.
Publicado: (2017)

AFF1 inhibits adipogenic differentiation via targeting TGM2 transcription
por: Chen, Yaqian, et al.
Publicado: (2020)

Diagnostic and Prognostic Values of Serum EpCAM, TGM2, and HE4 Levels in Endometrial Cancer
por: Lan, Ting, et al.
Publicado: (2020)

Tissue and serum expression of TGM-3 may be prognostic marker in patients of oral squamous cell carcinoma undergoing chemo-radiotherapy
por: Nayak, Seema, et al.
Publicado: (2018)

DNA methylation of the promoter region of bnip3 and bnip3l genes induced by metabolic programming
por: Veron, Vincent, et al.
Publicado: (2018)

Multiple Local and Recent Founder Effects of TGM1 in Spanish Families
por: Fachal, Laura, et al.
Publicado: (2012)

Correction: Tissue and serum expression of TGM-3 may be prognostic marker in patients of oral squamous cell carcinoma undergoing chemo-radiotherapy
por: Nayak, Seema, et al.
Publicado: (2018)

Plasma uric acid and tumor volume are highly predictive of outcome in nasopharyngeal carcinoma patients receiving intensity modulated radiotherapy
por: Lin, Hui, et al.
Publicado: (2013)

Inhibition of BMK1 pathway suppresses cancer stem cells through BNIP3 and BNIP3L
por: Song, Chengli, et al.
Publicado: (2015)

Bioactive Lactones from the Mangrove-Derived Fungus Penicillium sp. TGM112
por: Bai, Meng, et al.
Publicado: (2019)

WHICH PATIENTS SHOULD RECEIVE RADIOTHERAPY IN POSTOPERATIVE DISEASE RECURRENCE?
por: Matić, Mate, et al.
Publicado: (2019)

The novel cereblon modulator CC-885 inhibits mitophagy via selective degradation of BNIP3L
por: Hao, Bing-bing, et al.
Publicado: (2020)

BNIP3 in Lung Cancer: To Kill or Rescue?
por: Gorbunova, Anna S., et al.
Publicado: (2020)

Clinical significance of tumor-associated macrophage infiltration in supraglottic laryngeal carcinoma
por: Lin, Jia-Ying, et al.
Publicado: (2011)

The outer mitochondrial membrane protein TMEM11 demarcates spatially restricted BNIP3/BNIP3L-mediated mitophagy
por: Gok, Mehmet Oguz, et al.
Publicado: (2023)

Human antigen R regulates hypoxia‐induced mitophagy in renal tubular cells through PARKIN/BNIP3L expressions
por: Yu, Shao‐Hua, et al.
Publicado: (2021)

Compound Heterozygous Mutations in TGM1 Causing a Severe Form of Lamellar Ichthyosis: A Case Report
por: Zeng, Jing, et al.
Publicado: (2022)

Surgical thyroparathyroidectomy prevents progression of 5TGM1 murine multiple myeloma in vivo
por: Zangari, Maurizio, et al.
Publicado: (2018)

Propofol Suppresses Microglia Inflammation by Targeting TGM2/NF-κB Signaling
por: Hou, Yuanyuan, et al.
Publicado: (2021)

Methylation of TGM-3 Promoter and Its Association with Oral Squamous Cell Carcinoma (OSCC)
por: Shojaeian, Sorour, et al.
Publicado: (2021)

Novel TGM1 Gene Mutation in a Japanese Patient with Bathing Suit Ichthyosis
por: TANI, Naomi, et al.
Publicado: (2020)

Suppression of airway allergic eosinophilia by Hp‐TGM, a helminth mimic of TGF‐β
por: Chauché, Caroline, et al.
Publicado: (2022)

TGM2 accelerates migration and differentiation of BMSCs by activating Wnt/β-catenin signaling
por: Liu, Feng, et al.
Publicado: (2023)

Clinical and immunological characteristics of TGM3 in pan-cancer: A potential prognostic biomarker
por: Zhang, Wenqing, et al.
Publicado: (2023)

Expression and epigenetic regulatory mechanism of BNIP3 in clear cell renal cell carcinoma
por: Shao, Yanxiang, et al.
Publicado: (2018)

TAp73 transcriptionally represses BNIP3 expression
por: Petrova, Varvara, et al.
Publicado: (2015)

BNIP3 expression in bovine follicle and corpus luteum
por: NISHIMURA, Ryo, et al.
Publicado: (2017)

TGM3 functions as a tumor suppressor by repressing epithelial-to-mesenchymal transition and the PI3K/AKT signaling pathway in colorectal cancer
por: Feng, Yifei, et al.
Publicado: (2020)

Progress of preoperative and postoperative radiotherapy in gastric cancer
por: Zhang, Nan, et al.
Publicado: (2018)

Osthole regulates N6‐methyladenosine‐modified TGM2 to inhibit the progression of rheumatoid arthritis and associated interstitial lung disease
por: Lin, Xian, et al.
Publicado: (2023)

Congenital lamellar ichthyosis in Tunisia is caused by a founder nonsense mutation in the TGM1 gene
por: Louhichi, Nacim, et al.
Publicado: (2012)

TGM3, a candidate tumor suppressor gene, contributes to human head and neck cancer
por: Wu, Xiangbing, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_lh9j3mveibbhem3ii758032iqc